Meier, Christoph R. “Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase”. CHIMIA, vol. 60, no. 1-2, Feb. 2006, p. 54, https://doi.org/10.2533/000942906777675272.